Crystal (use as (R) * (E) *2* (4* (2* (5* (1* (3, 5* dichloro pyridine *4* Yl ) ethoxy) *1H* indazole *3* Yl ) vinyl) *1H* Pyrazole *1* Yl ) ethanol and FGFR inhibitor)

Title:

Crystal (use as (R) * (E) *2* (4* (2* (5* (1* (3, 5* dichloro pyridine *4* Yl ) ethoxy) *1H* indazole *3* Yl ) vinyl) *1H* Pyrazole *1* Yl ) ethanol and FGFR inhibitor)

Document Type and Number:

Japanese Patent JP5940547

Kind Code:

B2

Abstract:

The present invention provides crystalline (R)-(E)-2-(4-(2-(5-(1-(3,5 -dichloropyridin-4-yl)ethoxy)-1H-indazol-3-yl)vinyl)-1H-pyrazol-1-yl)ethanol useful in the treatment of cancer.

Inventors:

Benjamin Alan Disload

Application Number:

JP2013532838A

Publication Date:

June 29, 2016

Filing Date:

September 29, 2011

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Eli Lilly and Company

International Classes:

C07D401/14; A61K31/4439; A61P35/00

Domestic Patent References:

JP5555314B2
JP2004513882A
JP2009019030A
JP2007529500A
JP2006188522A
JP2003101968A1
JP2004509112A

Foreign References:

WO2010129509A1

Attorney, Agent or Firm:

Samejima Mutsumi
Masahiro Nitta
Kure Hidenori

Previous Patent: LED package mount

Next Patent: SEMICONDUCTOR IC CIRCUIT AND LASER PROCESSING THEREOF